2015
DOI: 10.1016/j.humpath.2014.10.017
|View full text |Cite
|
Sign up to set email alerts
|

A histomorphologic predictive model for axillary lymph node metastasis in preoperative breast cancer core needle biopsy according to intrinsic subtypes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 33 publications
0
7
0
Order By: Relevance
“…Furthermore, tumor size was found to be a major determinant of axillary metastasis development in HER2 positive and ER positive (either HER2 negative or positive) subgroups. Other authors have also demonstrated a higher risk of lymph node metastasis in patients with HER2 overexpression 31,32 . The present study did not find this correlation, which can be explained by the small number of patients with HER2+.…”
Section: Discussionmentioning
confidence: 86%
“…Furthermore, tumor size was found to be a major determinant of axillary metastasis development in HER2 positive and ER positive (either HER2 negative or positive) subgroups. Other authors have also demonstrated a higher risk of lymph node metastasis in patients with HER2 overexpression 31,32 . The present study did not find this correlation, which can be explained by the small number of patients with HER2+.…”
Section: Discussionmentioning
confidence: 86%
“…The prognostic and predictive factors in CNB have been assessed in previous publications. CNB has been reported to be accurate in evaluating ER, PR and HER2 status, and molecular subtype. Owing to its microfocal characteristics, a 30 per cent failure rate in detecting vascular invasion in the CNB has been reported, which is a limitation of the proposed nomograms, and caution is therefore warranted in interpreting vascular invasion on CNB.…”
Section: Discussionmentioning
confidence: 99%
“…l Biochemical (CEA, CA 15-3) l Genetic (BRCA 1, BRCA2, VEGFC, MIB1, CCR7, CXCR4 ) (24-60). Some of these investigations can be provided to the material taken from the tumor before the surgical intervention with "core" biopsy, which is very important for planning further therapeutic steps (42).…”
Section: Resultsmentioning
confidence: 99%